abstract |
The use of Bcl-xL inhibitor and oncolytic virus in the preparation of an anti-tumor drug is disclosed. Bcl-xL inhibitor can be used as an anti-tumor synergist for oncolytic virus. A pharmaceutical composition comprising Bcl-xL inhibitor and oncolytic virus, a pharmaceutical kit comprising Bcl-xL inhibitor and oncolytic virus, and use of Bcl-xL inhibitor and oncolytic virus for treating tumors are also disclosed. |